Ethinyl Estradiol 0.03 mg and Drospirenone 3 mg Tablets

Composition

Each film-coated tablet contains:

• Drospirenone IP — 3 mg
• Ethinylestradiol IP — 30 micrograms
• Excipients — q.s.

Pack: 1 × 21 tablets.

Indications & Uses

Estravus 30 is a combined oral contraceptive indicated for women of reproductive potential for:

• Prevention of pregnancy
• Effective reversible contraception
• Regulation of the menstrual cycle
• Reduction of excessive or irregular menstrual bleeding
• Relief from menstrual pain and discomfort
• Improvement of hormone-related bloating and fluid retention
• Potential improvement in androgen-related symptoms such as acne and oily skin

The primary approved indication is contraception. Other uses should be stated only when supported by the locally approved prescribing information.

Mechanism of Action

Estravus 30 provides contraception through complementary actions:

• Suppresses the hypothalamic–pituitary–ovarian axis and inhibits ovulation.
• Thickens cervical mucus, making sperm penetration more difficult.
• Produces endometrial changes that reduce the likelihood of implantation.
• Drospirenone provides progestogenic activity along with antiandrogenic and mild antimineralocorticoid properties.
• Ethinylestradiol supports ovulation suppression and helps maintain menstrual-cycle control.

The contraceptive effect primarily results from inhibition of ovulation and alteration of cervical secretions.

USPs

• Balanced combination of drospirenone 3 mg and ethinylestradiol 30 micrograms
• Reliable reversible contraception when taken correctly
• Effective suppression of ovulation
• Helps promote a regular and predictable menstrual cycle
• May reduce menstrual bleeding and period-related discomfort
• Drospirenone offers antiandrogenic properties
• May support improvement in acne and oily skin
• Mild antimineralocorticoid activity may help address hormone-related bloating and fluid retention
• Convenient once-daily, 21-tablet regimen
• Rapid return of fertility is generally expected after discontinuation
• Suitable for physician-selected women seeking contraception with additional cycle-control benefits

Important: Estravus 30 is a prescription combined hormonal contraceptive. It does not protect against HIV or other sexually transmitted infections. Patient suitability—including smoking status, age, thromboembolic risk, migraine history, blood pressure, liver/kidney/adrenal conditions and interacting medicines—must be assessed by a registered medical practitioner. Drospirenone-containing contraceptives also require attention to hyperkalaemia risk in susceptible patients.